BCA
MRK icon

Benchmark Capital Advisors’s Merck MRK Stock Holding History

Benchmark Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$1.92M Sell
26,357
-419
-2% -$29.6K 1.91% 15
2018
Q3 		$1.81M Sell
26,776
-2,306
-8% -$147K 1.36% 21
2018
Q2 		$1.68M Buy
+29,082
New +$1.64M 1.27% 24
2017
Q4 		– Sell
-17,082
Closed -$1.04M – 139
2017
Q3 		$1.04M Sell
17,082
-1,782
-9% -$108K 0.81% 38
2017
Q2 		$1.15M Sell
18,864
-210
-1% -$12.8K 0.91% 37
2017
Q1 		$1.16M Buy
19,074
+3,302
+21% +$200K 0.91% 35
2016
Q4 		$886K Buy
15,772
+314
+2% +$18.4K 0.73% 41
2016
Q3 		$921K Sell
15,458
-419
-3% -$24.5K 0.7% 45
2016
Q2 		$873K Sell
15,877
-6,178
-28% -$329K 0.71% 44
2016
Q1 		$1.11M Buy
22,055
+629
+3% +$30.8K 0.98% 34
2015
Q4 		$1.08M Sell
21,426
-629
-3% -$31.7K 0.91% 37
2015
Q3 		$1.04M Sell
22,055
-53
-0.2% -$2.81K 0.85% 39
2015
Q2 		$1.2M Buy
22,108
+963
+5% +$54K 0.84% 40
2015
Q1 		$1.16M Sell
21,145
-53
-0.3% -$3K 0.76% 42
2014
Q4 		$1.15M Sell
21,198
-209
-1% -$11.6K 0.77% 43
2014
Q3 		$1.21M Sell
21,407
-2,254
-10% -$127K 0.84% 39
2014
Q2 		$1.31M Sell
23,661
-1,177
-5% -$64.2K 0.82% 45
2014
Q1 		$1.34M Hold
24,838
– – 0.93% 37
2013
Q4 		$1.19M Buy
24,838
+3,249
+15% +$149K 0.82% 42
2013
Q3 		$981K Sell
21,589
-1,257
-6% -$57.4K 0.7% 47
2013
Q2 		$1.01M Buy
+22,846
New +$1.02M 0.78% 42

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Benchmark Capital Advisors's MRK Position: Q4 2018 in Review

Benchmark Capital Advisors reduced its Merck (MRK) stake by 1.6% in Q4 2018, selling an estimated $29.6K and leaving 26,357 shares worth $1.92M. The position accounts for 1.91% of the portfolio, ranked #15.

Benchmark Capital Advisors first reported a position in MRK in Q2 2013 and has held it in 21 quarters since. 2,251 funds tracked by Wall St. Rank hold MRK as of Q4 2018.

  • Benchmark Capital Advisors held 26,357 shares of Merck worth $1.92M as of Q4 2018.
  • Benchmark Capital Advisors sold 419 Merck shares in Q4 2018, an estimated $29.6K.
  • Merck made up 1.91% of Benchmark Capital Advisors's portfolio in Q4 2018, its #15 holding.
  • Benchmark Capital Advisors first reported a position in Merck in Q2 2013 and has held it in 21 quarters since.
  • 2,251 funds tracked by Wall St. Rank held Merck as of Q4 2018.

Based on Benchmark Capital Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.